Rbwin Trio 1mg/500mg/0.2mg Tablet SR
By Rbwin Trio
Rx
10 Tablet SR in a Strip

Composition
Glimepiride(1mg) + Metformin(500mg) + Voglibose(0.2mg)

Manufacturer - Minii Life Sciences Pvt Ltd
Plot No: 24 & 25, Mini House, Mahaveer Oaks Layout , Soppahalli, Off Jigani - Anekal Road, Bengaluru-562106, Karnataka, India

Expires on or after
October, 2025

liver
Rbwin Trio 1mg/500mg/0.2mg Tablet SR should be used carefully in individuals with liver issues. It may be necessary to adjust the dosage of Rbwin Trio 1mg/500mg/0.2mg Tablet SR in such cases. It is advised to seek guidance from your healthcare provider before using this medication. Typically, Rbwin Trio 1mg/500mg/0.2mg Tablet SR is initiated at a low dose for patients with mild to moderate liver problems. However, it is not recommended for use in individuals with severe liver disease.

kidney
Rbwin Trio 1mg/500mg/0.2mg Tablet SR may not be safe for patients with kidney disease and is not recommended for those with severe kidney issues. Consult your doctor before use.

alcohol
It is unsafe to consume alcohol with Rbwin Trio 1mg/500mg/0.2mg Tablet SR. Avoid alcohol when taking this medication. Caution - Pregnancy It is important to consult your doctor regarding alcohol consumption with Rbwin Trio 1mg/500mg/0.2mg Tablet SR during pregnancy.

driving
To ensure safety, avoid driving if experiencing low or high blood sugar symptoms while taking Rbwin Trio 1mg/500mg/0.2mg Tablet SR.

pregnancy
Rbwin Trio 1mg/500mg/0.2mg Tablet SR may be harmful during pregnancy based on animal studies. Consult your doctor to assess potential risks and benefits before using it.

breastfeeding
Rbwin Trio 1mg/500mg/0.2mg Tablet SR is likely unsafe during breastfeeding. Limited data indicates it may pass into breastmilk and harm the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹135
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024